Bacteriocins—Potential Clinical Antimicrobials
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 929
Special Issue Editor
Interests: Quorum Sensing; Acyl-Butyrolactones; N-Octanoylhomoserine Lactone; Raw Milk; Psychrotrophic Bacteria; Spoilage; Bacteriocins; Lactobacillales; Biopreservatives
Special Issue Information
Dear Colleagues,
The introduction of penicillin for treatments for bacterial infections in the 1940s has been recognized as one of the greatest advances in therapeutic medicine. However, the world is facing a significant increase in infections caused by drug-resistant agents. There is an urgent need to take another revolutionary step and develop new antimicrobial agents, specifically those directed against multi-drug resistant bacteria. In this scenario, bacteriocins fit as a promising and interesting alternative to conventional antibiotics in medical applications as potential antimicrobials and as possible immune-modulating agents. Bacteriocins are of bacterial origin and can be easily manipulated by bioengineering techniques. Although its potential as a food preservative is well explored, insufficient data on safety, toxicity, and clinical application represent a barrier to developing new therapeutic strategies. This Special Issue will collect original research, reviews, mini-reviews, perspectives, and opinion articles on the clinical application of bacteriocins. The proposal intends to bring together works that add knowledge to a better understanding of the bacteriocins as clinical antimicrobials and, in turn, contribute to developing more efficient strategies for combating infectious bacteria.
Prof. Dr. Maria Cristina Dantas Vanetti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- new antimicrobials
- antimicrobial peptides
- bioactive agents
- bacteriocins toxicity
- mechanism of action
- antibacterial activity
- drug tolerance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
